강북삼성병원은 서울특별시 종로구 새문안로 29 에 위치한 상급종합병원이다. 삼성그룹 계열의 병원이며 삼성의료원에서 운영하고 있다.

During the past decade, Kangbuk Samsung Hospital conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 38 clinical trials were completed, i.e. on average, 21.6% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 32 clinical trials were completed. i.e. 48.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kangbuk Samsung Hospital" #1 sponsor was "Kangbuk Samsung Hospital" with 36 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Janssen Research & Development, LLC" with 13 trials sponsored, "Takeda" with 11 trials sponsored and "Celgene" with 11 trials sponsored. Other sponsors include 127 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kangbuk Samsung Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 9 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "Korean Cancer Study Group" with 4 trials as a collaborator, "Medtronic" with 4 trials as a collaborator and "Biotronik SE & Co. KG" with 3 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Kangbuk Samsung Hospital" are "Ulcerative Colitis" (16 trials), "Crohn's Disease" (15 trials), "Coronary Artery Disease" (12 trials), "Crohn Disease" (11 trials) and "Colitis, Ulcerative" (9 trials). Many other conditions were trialed in "Kangbuk Samsung Hospital" in a lesser frequency.

Most popular intervention types in "Kangbuk Samsung Hospital" are "Drug" (154 trials), "Device" (19 trials), "Other" (18 trials), "Procedure" (15 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "Atezolizumab" (7 trials), "Desflurane" (6 trials), "Sevoflurane" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kangbuk Samsung Hospital" are 190 trials for "All" genders and 24 trials for "Female" genders.

Currently, there are NaN active trials in "Kangbuk Samsung Hospital". undefined are not yet recruiting, 47 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 102 completed trials in Kangbuk Samsung Hospital, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Kangbuk Samsung Hospital, 7 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 34 trials that are defined as “Not Applicable".